GC/52/2 - IARC

Publications du personnel du CIRC 2008–2009
Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D,
Brennan P, Aghcheli K, Merat S, Pourshams A, Marjani
HA, Ebadati A, Sotoudeh M, Boffetta P, Malekzadeh
R, Dawsey SM (2008). Tooth loss and lack
of regular oral hygiene are associated with higher
risk of esophageal squamous cell carcinoma. Cancer
Epidemiol Biomarkers Prev 17(11):3062-3068.
Achatz MI, Hainaut P, Ashton-Prolla P (2009). Highly
prevalent TP53 mutation predisposing to many
cancers in the Brazilian population: a case for newborn
screening? Lancet Oncol 10(9):920-925.
Akbari MR, Malekzadeh R, Nasrollahzadeh D,
Amanian D, Islami F, Li S, Zandvakili I, Shakeri R,
Sotoudeh M, Aghcheli K, Salahi R, Pourshams A,
Semnani S, Boffetta P, Dawsey SM, Ghadirian P,
Narod SA (2008). Germline BRCA2 mutations and
the risk of esophageal squamous cell carcinoma.
Oncogene 27(9):1290-1296.
Akbari MR, Malekzadeh R, Shakeri R, Nasrollahzadeh
D, Foumani M, Sun Y, Pourshams A, Sadjadi
A, Jafari E, Sotoudeh M, Kamangar F, Boffetta P,
Dawsey SM, Ghadirian P, Narod SA (2009). Candidate
gene association study of esophageal squamous
cell carcinoma in a high-risk region in Iran.
Cancer Res 69(20):7994-8000.
Allen NE, Appleby PN, Roddam AW, Tjonneland
A, Johnsen NF, Overvad K, Boeing H, Weikert S,
Kaaks R, Linseisen J, Trichopoulou A, Misirli G, Trichopoulos
D, Sacerdote C, Grioni S, Palli D, Tumino
R, Bueno-de-Mesquita HB, Kiemeney LA, Barricarte
A, Larranaga N, Sanchez MJ, Agudo A, Tormo
MJ, Rodriguez L, Stattin P, Hallmans G, Bingham
S, Khaw KT, Slimani N, Rinaldi S, Boffetta P, Riboli
E, Key TJ (2008). Plasma selenium concentration
and prostate cancer risk: results from the European
Prospective Investigation into Cancer and Nutrition
(EPIC). Am J Clin Nutr 88(6):1567-1575.
Allen NE, Key TJ, Appleby PN, Travis RC, Roddam
AW, Tjonneland A, Johnsen NF, Overvad K, Linseisen
J, Rohrmann S, Boeing H, Pischon T, Buenode-Mesquita
HB, Kiemeney L, Tagliabue G, Palli D,
Vineis P, Tumino R, Trichopoulou A, Kassapa C, Trichopoulos
D, Ardanaz E, Larranaga N, Tormo MJ,
Gonzalez CA, Quiros JR, Sanchez MJ, Bingham S,
Khaw KT, Manjer J, Berglund G, Stattin P, Hallmans
G, Slimani N, Ferrari P, Rinaldi S, Riboli E (2008).
Animal foods, protein, calcium and prostate cancer
risk: the European Prospective Investigation into
Cancer and Nutrition. Br J Cancer 98(9):1574-1581.
Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A,
Lukanova A, Peeters PH, Onland-Moret NC, Lahmann
PH, Berrino F, Panico S, Larranaga N, Pera
G, Tormo MJ, Sanchez MJ, Ramon QJ, Ardanaz E,
Tjonneland A, Olsen A, Chang-Claude J, Linseisen
J, Schulz M, Boeing H, Lundin E, Palli D, Overvad K,
Clavel-Chapelon F, Boutron-Ruault MC, Bingham
S, Khaw KT, Bas Bueno-de-Mesquita H, Trichopoulou
A, Trichopoulos D, Naska A, Tumino R, Riboli E,
Kaaks R (2008). Endogenous sex hormones and
endometrial cancer risk in women in the European
Prospective Investigation into Cancer and Nutrition
(EPIC). Endocr Relat Cancer 15(2):485-497.
Allen NE, Roddam AW, Sieri S, Boeing H, Jakobsen
MU, Overvad K, Tjonneland A, Halkjaer J, Vineis P,
Contiero P, Palli D, Tumino R, Mattiello A, Kaaks R,
Rohrmann S, Trichopoulou A, Zilis D, Koumantaki Y,
Peeters PH, Bueno-de-Mesquita HB, Barricarte A,
Rodriguez L, Dorronsoro M, Sanchez MJ, Chirlaque
MD, Esquius L, Manjer J, Wallstrom P, Ljungberg
B, Hallmans G, Bingham S, Khaw KT, Boffetta P,
Norat T, Mouw T, Riboli E (2009). A prospective
analysis of the association between macronutrient
intake and renal cell carcinoma in the European
Prospective Investigation into Cancer and Nutrition.
Int J Cancer 125(4):982-987.
Amundadottir L, Kraft P, Stolzenberg-Solomon RZ,
Fuchs CS, Petersen GM, Arslan AA, Bueno-de-
Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ,
Lacroix A, Zheng W, Albanes D, Bamlet W, Berg
CD, Berrino F, Bingham S, Buring JE, Bracci PM,
Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio
M, de Andrade M, Duell EJ, Fox JW, Jr., Gallinger
S, Gaziano JM, Giovannucci EL, Goggins M, Gonzalez
CA, Hallmans G, Hankinson SE, Hassan M,
Holly EA, Hunter DJ, Hutchinson A, Jackson R,
Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg
C, Kurtz RC, Li D, Lynch SM, Mandelson M,
McWilliams RR, Mendelsohn JB, Michaud DS, Olson
SH, Overvad K, Patel AV, Peeters PH, Rajkovic
A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias
GS, Trichopoulos D, Van Den Eeden SK, Virtamo J,
Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte
A, Chanock SJ, Hartge P, Hoover
RN (2009). Genome-wide association study
identifies variants in the ABO locus associated
with susceptibility to pancreatic cancer. Nat Genet
41(9):986-990.
Andersson L, Droller MJ, Adolfsson J, Mansson W,
Kirkali Z, Boffetta P, Montironi R, Malmstrom PU,
Tribukait B, Grossman HB (2008). Chairmen’s
summary. Scand J Urol Nephrol (Supp 218):7-11.
Andrew AS, Mason RA, Memoli V, Duell EJ (2009).
Arsenic activates EGFR pathway signaling in the
lung. Toxicol Sci 109(2):350-357.
Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick
J, Rebolj M, Nicula F, Vass L, Valerianova Z,
Voti L, Sauvaget C, Ronco G (2009). Cervical cancer
screening policies and coverage in Europe. Eur
J Cancer 45(15):2649-2658.
Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch
P, Siebers AG, Bulten J (2008). Liquid compared
with conventional cervical cytology: a systematic
review and meta-analysis. Obstet Gynecol
111(1):167-177.
Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos
G, Martin-Hirsch P, Prendiville W, Paraskevaidis
E (2008). Perinatal mortality and other
severe adverse pregnancy outcomes associated
with treatment of cervical intraepithelial neoplasia:
meta-analysis. BMJ 337:a1284.
Arbyn M, Sankaranarayanan R, Muwonge R, Keita
N, Dolo A, Mbalawa CG, Nouhou H, Sakande B,
Wesley R, Somanathan T, Sharma A, Shastri S,
Basu P (2008). Pooled analysis of the accuracy
of five cervical cancer screening tests assessed
in eleven studies in Africa and India. Int J Cancer
123(1):153-160.
Arbyn M and Cuzick J (2009). International agreement
to join forces in synthesizing evidence on new
methods for cervical cancer prevention. Cancer Lett
278(1):1-2.
Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle
PE (2009). How to evaluate emerging technologies
in cervical cancer screening? Int J Cancer
125(11):2489-2496.
Arbyn M, Ronco G, Meijer CJ, Naucler P (2009).
Trials comparing cytology with human papillomavirus
screening. Lancet Oncol 10(10):935-936.
Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M,
Paraskevaidis E, Dillner J (2009). Triage of women
with equivocal or low-grade cervical cytology results:
a meta-analysis of the HPV test positivity rate.
J Cell Mol Med 13(4):648-659.
Ariffin H, Martel-Planche G, Daud SS, Ibrahim
K, Hainaut P (2008). Li-Fraumeni syndrome in
a Malaysian kindred. Cancer Genet Cytogenet
186(1):49-53.
Arnold S, Buchanan DD, Barker M, Jaskowski L,
Walsh MD, Birney G, Woods MO, Hopper JL, Jenkins
MA, Brown MA, Tavtigian SV, Goldgar DE,
Young JP, Spurdle AB (2009). Classifying MLH1
and MSH2 variants using bioinformatic prediction,
splicing assays, segregation, and tumor characteristics.
Hum Mutat 30(5):757-770.
Arrossi S, Ramos S, Paolino M, Sankaranarayanan
R (2008). Social inequality in Pap smear coverage:
identifying under-users of cervical cancer screening
in Argentina. Reprod Health Matters 16(32):50-58.
Aune D, De Stefani E, Ronco A, Boffetta P, Deneo-
Pellegrini H, Acosta G, Mendilaharsu M (2009). Lepublications
du personnel du circ 2008-2009
145